← FDA DRUG APPROVALS

FDA NDA · NDA021105

SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE

Sponsor: ABLE

APPLICATION
NDA021105
TYPE
NDA
ORIGINAL APPROVAL
2001-06-26
LATEST ACTION
2001-06-26
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDEDiscontinued
PHENAZOPYRIDINE HYDROCHLORIDE 200MG,N/A,N/A, SULFAMETHOXAZOLE N/A,800MG,160MG, TRIMETHOPRIM · TABLET · ORAL

Approval history

2001-06-26Type 4 - New Combination · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →